AXL and Alzheimer disease: Similarly, using Aβ-treated SK-N-SH and SK-SY5Y cell lines, a study suggested that circRNA AXL increased neuronal injury and inflammation by targeting microRNA-328-mediated BACE1 in AD (Li Y. et al., 2022).